tiprankstipranks
Black Diamond Therapeutics (BDTX)
NASDAQ:BDTX
US Market
Holding BDTX?
Track your performance easily

Black Diamond Therapeutics (BDTX) Financial Statements

855 Followers

Black Diamond Therapeutics Financial Overview

Black Diamond Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.363; its P/E ratio is -1.63; Black Diamond Therapeutics is scheduled to report earnings on March 12, 2025, and the estimated EPS forecast is $-0.31. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 989.00K$ 615.00K$ 456.00K$ 1.00M-
Gross Profit$ 989.00K$ 615.00K$ 456.00K$ 334.00K$ 334.00K
EBIT$ -15.56M$ -19.91M$ -18.23M$ -19.41M$ -24.01M
EBITDA$ -15.47M$ -19.82M$ -18.14M$ -19.32M$ -23.90M
Net Income Common Stockholders$ -15.56M$ -19.91M$ -18.23M$ -19.41M$ -23.01M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 112.68M$ 122.97M$ 115.20M$ 131.40M$ 144.26M
Total Assets$ 137.90M$ 149.99M$ 142.52M$ 158.57M$ 172.38M
Total Debt$ 19.67M$ 20.53M$ 21.36M$ 22.18M$ 23.00M
Net Debt$ -93.01M$ -102.44M$ -93.84M$ -109.22M$ -121.26M
Total Liabilities$ 40.47M$ 38.97M$ 38.22M$ 41.83M$ 38.06M
Stockholders Equity$ 97.43M$ 110.99M$ 104.31M$ 116.74M$ 134.32M
Cash Flow-
Free Cash Flow$ -11.28M$ -14.69M$ -21.20M$ -13.96M$ -18.39M
Operating Cash Flow$ -11.32M$ -14.73M$ -21.20M$ -13.96M$ -18.36M
Investing Cash Flow$ 2.19M$ 740.00K$ -13.73M$ 12.25M$ -37.88M
Financing Cash Flow$ -252.00K$ 21.38M$ 4.13M$ -46.00K$ 71.93M
Currency in USD

Black Diamond Therapeutics Earnings and Revenue History

Black Diamond Therapeutics Debt to Assets

Black Diamond Therapeutics Cash Flow

Black Diamond Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis